Delcath Systems

Closed
1633 Broadway
NY

Delcath Systems Inc. is a commercial-stage interventional oncology company focused on advancing treatment options for patients with primary and metastatic liver cancers. With a commitment to innovative and minimally-invasive therapies, Delcath aims to lead the field in providing targeted solutions for individuals affected by liver metastases.

The company's FDA-approved treatment, HEPZATO KIT, is specifically designed for adult patients with metastatic Uveal Melanoma, while its European counterpart, CHEMOSAT, offers a similar approach for hepatic delivery. In a landscape where liver cancers impact 1.2 million people globally each year, Delcath is dedicated to pioneering new pathways for effective treatment.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesNew YorkDelcath Systems

Partial Data by Foursquare.